ASPHO Webinars Connect Learners to the Latest in Pediatric Hematology/Oncology Clinical Treatment, Best Practices, and Professional Development
ASPHO and its partners create presentations led by experts in clinical and career topics of broad interest to pediatric hematology/oncology specialists. Webinar attendees can participate live and ask presenters and moderators questions, or they can watch a recorded version after the event. Stay informed with convenient, on-demand education designed for today's pediatric hematology/oncology practitioner.
Hear what attendees say about ASPHO Webinars:
"Great information sharing and something that I can definitely take back to my team."
"Wonderful, informative, useful information."
Webinars are free to members; $35 for non-members.
Each webinar is an hour-long, with 45 minutes of lecture and 15 minutes of live Q&A.
The Education Committee is pleased to announce the 2021-2022 webinar schedule:
Standard Approach to the Diagnosis of Myelodysplastic Syndrome (MDS) in Pediatrics
- Wednesday, October 27, 3pm CT
- Moderator: Jennifer Rothman, MD
- Speakers: Timothy Olson, MD PhD, Marcin Wlodarski, MD PhD
Pediatric myelodysplastic syndrome (MDS) is a rare disease in children and clinically distinct from adult MDS. Differentiating primary from secondary MDS is critically important to understanding prognosis and treatment outcomes. Understanding which screening tests to send, both functional and emerging molecular testing, as well as interpreting ambiguous results, is an ongoing challenge for clinicians when developing a treatment plan for newly diagnosed patients with MDS. This is particularly challenging due to the rarity of the disorder as well as the, sometimes, limited availability of specialized testing in many settings. The goal of this webinar is to review a standardized approach to the diagnosis of MDS and associated conditions developed by the North American Aplastic Anemia Consortium (NAPAAC) as well as discuss benefits and limitations of specialized testing. PHO learners will be provided with a diagnostic framework to approach these challenging patients.
- Identify clinical and laboratory studies that are essential in the diagnosis of pediatric myelodysplastic syndrome
- Distinguish primary and secondary MDS
Diversity in the Scientific Workforce
- Wednesday, November 3, 3pm CT
- Moderator: Maa-Ohui Quarmyne, MD
- Speakers: Tamara New, MD, Nidhi Shah, DO
The webinar will present evidence for why diversity is important for the scientific and medical workforce, as well as an overview of key issues in this area. The presentation will offer a socio-cultural perspective to better understand the factors that impact an individual's decision to enter and stay in a scientific/medical career. Some of these factors could be influenced by gender, stage of career, ethnicity, mentorship, potential for career advancement, as well as geographic influences. The goal is to use this perspective to illuminate new thinking and practices for more inclusive scientific workforce training and career development.
Attendees of the webinar will gain important tools and information to apply these concepts to their daily work:
- The presentation will explain diversity and inclusion concepts and scientific studies that are relevant in everyday physicians' practices. Implicit bias, stereotyping and communication across cultural groups not only affect interactions with patients but also with other physicians that subtly shape a workplace culture.
- The presentation provides a brief update on the current initiatives and goals of ASPHO's Diversity Advisory Group.
- Understand why diversity is important in medical and scientific workforce
- Gain a better understanding of the social and cultural factors that affect individuals' career decisions, which in turn affect the composition of the scientific and medical workforce
Overcoming Obstacles to Advancement for Women in Medicine
- Wednesday, December 8, 3pm CT
- Moderator: Carolyn Bennett, MD
- Speakers: Diane J. Nugent MD, Ify Osunkwo MD MPH, Sharon Castellino MD MSc
While advances have been made regarding gender inequality in medicine, obstacles to career advancement for women still exist. Women physicians are often paid less and achieve less recognition than men for the equivalent work. Women have fewer leadership roles in academia and are passed over for tenure more frequently than their male counterparts. Women have gender-specific issues that impact career advancement and these issues may not be recognized or addressed by traditional academic institutions. We believe that developing strategies to facilitate the career advancement of women in Pediatric Hematology/Oncology (PHO) should be an important goal of ASPHO and PHO programs in general.
This webinar will present data regarding gender inequality in medicine and include real-life scenarios that women have faced and overcome in their own medical careers. We hope to initiate a discussion of gender inequality within PHO, and assist the audience in formulating realistic and impactful solutions to issues that affect women in medicine. Our ultimate goal is to develop ideas, recommendations and potential strategies to facilitate career advancement for women in PHO.
- Educate participants on the current statistics of gender inequality in the field of medicine and PHO.
- Identify and discuss the unique, real-life challenges that women encounter in their pathway to success
- Develop and share successful strategies for women in achieving successful work-life integration
Integrative Oncology in Pediatrics:, Programmatic Development Framework, Needs, and Challenges
- Wednesday, January 19, 3 pm CT
- Moderator: Ashraf Mohamed, MD MHA
- Speakers: Allison Ast, MD, Shana S. Jacobs, MD
Pediatric academic institutions have the opportunity to develop, integrate, and study initiatives to improve symptomatic care, meet family's information needs, and improve health outcomes through integrative healthcare. We Will share with the audience the clinical and administrative experiences from 3 different Institutions at deferent levels of programmatic development and implementation of Pediatric Integrative Oncology . We will highlight facilitators and barriers to integration of Pediatric Integrative Oncology service.
- Appreciate the facilitators and barriers to integration of Pediatric Integrative Oncology service.
- Maximize the use of the already available local institution Integrative modalities to improve patient's comfort and care giver satisfaction
- Develop Quality Improvement measures to assess the success of the program
Enhancing Patient Care Guidelines and Research Involvement of Patients and Patient Advocates at All Stages
- Thursday, February 17, 3 pm CT
- Moderator: Irina Pateva, MD
- Speakers: Marianne Clancy, RDH MPA, Mellenee Finger
Vascular anomalies are rare disorders and many patients suffer from chronic debilitating conditions that may require a variety of interventions throughout their lives. Advances in diagnosis and evidence-based therapies have elevated the standard of care for patients with vascular anomalies. Increased collaboration of medical professionals with patients and patient advocacy groups has enriched the experience of designing research studies, defining outcomes and creating clinical practice guidelines. (Ciccarella et al., 2018)
Pediatric Hematologists/Oncologists are increasingly involved in the care of patients with vascular anomalies, as the treatments are becoming more medically based. A multidisciplinary approach, together with advocacy group involvement, has led to creation of diagnostic algorithms and practice guidelines for several rare conditions. We will review recently published guidelines in order to build knowledge and alert our pediatric hematology/oncology colleagues to existing resources both in the medical literature and through patient advocacy groups. We will also discuss the paradigm of empowering patients to be partners with physicians and scientists throughout the research continuum and collaborators for best patient care. Our invited patient representatives are well renowned participants in real time in such initiatives. The knowledge gained will be applicable to other areas of practice within the pediatric hematology/oncology field.
- Review recently published clinical practice guidelines for management of patients with vascular anomalies, for example: Hereditary Hemorrhagic Telangiectasia; Complicated Lymphatic Anomalies; Hepatic Hemangiomas
- Describe the role of patient advocacy groups in the creation of clinical practice guidelines and in research studies
- Review successful outcomes and barriers to collaboration between physician societies and patient advocacy groups
Our Most Vital Procedure: Best Practices for High-Stakes Communication
- Tuesday, March 8, 3 pm CT
- Moderator: Katharine Brock, MD MS
- Speakers: Jennifer Snaman, MD, Angela M. Feraco, MD MMSc
Communication is the one procedure that all pediatric hematology/oncology (PHO) clinicians perform daily, yet clinicians receive little training and mostly learn via trial and error. Pediatric hematology/oncology today includes many therapeutic options that did not exist 10 years ago. New cellular therapies, genetic discoveries, and virtual visits have changed the landscape for many conditions, yet patients, families and clinicians must still contend with uncertainty, offer recommendations, and make decisions. How ready are we? Some conversations feel particularly high-stakes, and these are often the conversations that patients and clinicians find most difficult. Optimal communication promotes care that matches patients' values and wishes. For clinicians, it reduces moral distress, builds confidence and credibility, and saves time. We seek to provide concrete guidance for clinicians who may have a role in discussing prognosis, goals of care, decision-making, and advance care planning. The newest literature will be reviewed including conversation guides like the Serious Illness Communication Guide, the GOAL framework, the Day100 talk, Voicing My Choices, and technology-based supports like MyPref. We provide special focus on supporting and diversifying hope (over and above cure) and involving children in the decision-making process.
- Demonstrate the steps of a prognosis and goals of care discussion.
- Utilize conversation guides and frameworks to help families identify and share hopes, worries, and expectations when a child is seriously ill.
- Model age-appropriate methods for involving children, teens, and young adults in the decision-making process.
More information regarding registration and final schedules will be posted as it is available.
All webinars are available for on-demand purchase.
Planning for Your Future
Sponsored by Northwestern Mutual
- Speaker: William Taylor, JD, CLU, Vice President - Financial Planning and Sales Support Division, Northwestern Mutual
You have chosen an admirable career and your time is precious. You don’t have time to be an expert on personal finances. This career development webinar, ‘Planning for your Future’, touches on the components of a strong financial plan, considerations for medical professionals, and what to expect from your financial advisor.
Standard Approach to the Diagnosis of Severe Aplastic Anemia in Pediatrics
- Moderator: Jennifer Rothman, MD
- Speaker: Akiko Shimamura, MD PhD, and Alison A. Bertuch, MD PhD
With an increase in potential therapeutic options for severe aplastic anemia, it is increasing important to differentiate idiopathic or immune mediated aplasia from progressive aplasia associated with inherited bone marrow failure syndromes or hypoplastic MDS. Understanding which screening tests to send, both functional and emerging molecular testing, as well as interpreting ambiguous results, is an ongoing challenge for clinicians when developing a treatment plan for newly diagnosed patients with SAA. This is particularly challenging due to the rarity of the disorder as well as the, sometimes, limited availability of specialized testing in many settings. The goal of this webinar is to review a standardized approach to the diagnosis of SAA and associated conditions developed by the North American Aplastic Anemia Consortium (NAPAAC) as well as discuss benefits and limitations of specialized testing. PHO learners will be provided with a diagnostic framework to approach these challenging patients.
- Identify clinical and laboratory studies that are essential in the diagnosis of severe aplastic anemia
- Distinguish severe aplastic anemia for other causes such as MDS and inherited bone marrow failure syndromes.
Recordings of all webinars can be accessed through the Knowledge Center.